UNSPSC 51385703: Tilmacoxib

This classification denotes a cyclooxygenase inhibitor with the molecular formula C16H19FN2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G6VI5P84SX, chemically known as 5-ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo(4,5)imidazo(1,2a)pyridine-4-n-(2-fluorophenyl)carboxamide but generally known as tilmacoxib, which bears US NIH Compound Identifier 159271. The term TILMACOXIB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 No. 3-4, 2001, List 46).

Most nations schedule tilmacoxib under HS 29350090 and SITC 51580. As of Q4 2014, TILMACOXIB remains the US FDA Preferred Term for this commodity. Tilmacoxib bears US NLM identifiers UMLS ID C2699944 and NCI Concept Code C76640. SMILES: CC1=NC(=C(O1)C2=CC(=C(C=C2)S(=O)(=O)N)F)C3CCCCC3.

UNSPSC 51385703 Tilmacoxib is a Commodity code that captures pharmaceutical products purchased by state and local health and safety agencies, though recent solicitation activity shows minimal state and local procurement specifically under this code designation. The single recent opportunity on record—Seminole County, Florida's IFB for naloxone and drug deactivation systems—was tagged with this code but represents emergency medical supplies and harm-reduction equipment rather than the specific active pharmaceutical ingredient the code nominally describes. State and local buyers soliciting under this code family tend to be county health departments and community health initiatives focused on opioid response and overdose prevention, with quarterly delivery cycles and fixed-fee contracting structures. Vendors must meet standard federal compliance requirements including E-Verify confirmation, drug-free workplace certification, and appropriate insurance coverage.

Seminole County's June 30, 2026 IFB (IFB60459723LAS) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023 response deadline, reflecting the county's ongoing community health support mission. The procurement specified quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with vendors responsible for all shipping costs and electronic bid submission through the county's e-procurement portal. The contract structure included an initial two-year term with a one-year renewal option and a three-month probationary termination period. Activity under this code remains sparse; this single recent opportunity in Florida provides limited geographic spread or repeat-buyer signals for capacity planning.